All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-CQ0706 | Anti-CXCL11 (CBXC-2347) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXC-2347 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ0707 | Anti-CXCL11 (CBXC-1341) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXC-1341 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ0708 | Anti-CXCL11 (CBXC-1492) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse | CBXC-1492 | Rat | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
XS-1222-ZP492 | CXCL11 (ACKR3 Receptor) h(CD28-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | CXCL11-CD28-CD6ζ | Lentiviral vector | T cell | ||||
XS-1222-ZP493 | CXCL11 (CCR3 Receptor) h(CD28-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | CXCL11-CD28-CD6ζ | Lentiviral vector | T cell | ||||
XS-1222-ZP494 | CXCL11 (CXCR3 Receptor) h(CD28-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | CXCL11-CD28-CD6ζ | Lentiviral vector | T cell | ||||
XS-1222-ZP1892 | CXCL11 (ACKR3 Receptor) h(41BB-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | CXCL11-41BB-CD6ζ | Lentiviral vector | T cell | ||||
XS-1222-ZP1893 | CXCL11 (CCR3 Receptor) h(41BB-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | CXCL11-41BB-CD6ζ | Lentiviral vector | T cell | ||||
XS-1222-ZP1894 | CXCL11 (CXCR3 Receptor) h(41BB-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | CXCL11-41BB-CD6ζ | Lentiviral vector | T cell | ||||
XS-0323-LX1096 | Anti-CXCL11 VHH(X3XH358) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH358 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1097 | Anti-CXCL11 VHH(X3XH359) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH359 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1098 | Anti-CXCL11 VHH(X3XH360) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH360 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1099 | Anti-CXCL11 VHH(X3XH361) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH361 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1100 | Anti-CXCL11 VHH(X3XH362) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH362 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1101 | Anti-CXCL11 VHH(X3XH363) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH363 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1102 | Anti-CXCL11 VHH(X3XH364) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH364 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1103 | Anti-CXCL11 VHH(X3XH365) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH365 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1104 | Anti-CXCL11 VHH(X3XH366) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH366 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1105 | Anti-CXCL11 VHH(X3XH367) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH367 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1106 | Anti-CXCL11 VHH(X3XH368) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH368 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0823-LX33 | Anti-hCXCL11 (E6) ICD(CD28-OX40-CD3ζ) CAR-MA, pAd5f35 Vector | Human | E6 | Adenoviral vectors |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION